Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$14.49 0.53 | 3.8%
07/27/16 - 04:00 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -352.86M -160.03M -84.53M -73.98M
Operating Gains/Losses 39.00K 67.00K 0.00 1.16M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 8.11M -1.37M 958.00K -758.00K
(Decrease) Increase In Other Current Liabilities 5.29M 3.88M -2.20M -110.00K
(Increase) Decrease In Other Working Capital -4.38M -910.00K 0.00 0.00
Other Non-Cash Items 102.12M 18.22M 10.53M 4.95M
Net Cash From Continuing Operations -253.07M -117.05M -71.71M -65.38M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -253.07M -117.05M -71.71M -65.38M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 2.00M
Purchases of Property, Plant & Equipment -3.04M -2.29M -121.00K -1.06M
Acquisitions 0.00 0.00 -9.91M 0.00
Purchases of Short-Term Investments -392.54M 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -254.58M -2.29M -10.03M 942.00K
Issuance of Debt 0.00 287.50M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 304.48M 1.16M 260.84M 70.29M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -9.19M 0.00 0.00
Net Cash From Financing Activities 304.48M 279.48M 260.84M 70.29M
Effect of Exchange Rate Changes -757.00K -690.00K 35.00K 12.00K
Net Change in Cash & Cash Equivalents -203.92M 159.45M 179.13M 5.86M

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter